Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05164> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05164 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05164 label "CMLVAX100 [drugbank:DB05164]" assertion.
- drugbank:DB05164 seeAlso DB05164 assertion.
- drugbank:DB05164 identifier "drugbank:DB05164" assertion.
- drugbank:DB05164 description "CMLVAX100 is a vaccine targeting the BCR-ABL-derived p210 fusion protein which reduces residual disease in some patients with chronic myeloid leukemia. It is developed by Breakthrough Therapeutics and has completed phase I of its clinical trial." assertion.
- drugbank:DB05164 title "CMLVAX100" assertion.
- drugbank:DB05164 bio2rdf_vocabulary:identifier "DB05164" assertion.
- drugbank:DB05164 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05164 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05164" assertion.
- drugbank:DB05164 bio2rdf_vocabulary:x-identifiers.org DB05164 assertion.
- drugbank:DB05164 drugbank_vocabulary:drugbank-id "DB05164" assertion.
- drugbank:DB05164 drugbank_vocabulary:x-cas cas: assertion.